Literature DB >> 34329441

Immunotyping Provides Equivalent Results to Immunofixation in a Population with a High Prevalence of Monoclonal Gammopathies.

Katie L Thoren1, Samuel I McCash1, Kazunori Murata1.   

Abstract

BACKGROUND: Serum immunofixation (IF) is a common laboratory test used to diagnose and monitor patients with monoclonal gammopathies. Similarly, immunotyping (IT) by capillary electrophoresis can confirm the presence of a monoclonal protein (M-protein) and determine its isotype. The goal of this study was to compare the ability of IT and IF to detect M-proteins.
METHODS: IT and IF results for 1000 waste clinical serum samples were obtained. All results were interpreted blindly by reviewers who were experienced in each technique. Results were compared by band. Results were also compared to patient history to determine if the original clone was present. We determined the sensitivity of IT and IF alone and in combination with additional tests. Finally, we evaluated the impact of reviewer training on the sensitivity of IT.
RESULTS: IT and IF were concordant in 721/773 (93%) samples with a history of an intact M-protein and in 143/172 (83%) samples with a history of a free light chain (FLC) M-protein. IF was significantly more sensitive than IT for the detection of FLC M-proteins (P < 0.0001). However, IF was not more sensitive than IT for detection of intact M-proteins (P = 0.1272) or when each test was combined with the FLC ratio or urine immunofixation (P = 0.2812 and P = 0.6171, respectively). Finally, after training, inexperienced reviewers improved their IT sensitivity by 19%.
CONCLUSION: IT provides equivalent results to IF for the detection of monoclonal proteins. Training and experience are critical to the accurate interpretation of IT. © American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  M-protein; immunofixation; immunotyping; monoclonal gammopathies

Mesh:

Substances:

Year:  2021        PMID: 34329441      PMCID: PMC8561783          DOI: 10.1093/jalm/jfab067

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


  11 in total

1.  Clarification of the definition of complete response in multiple myeloma.

Authors:  B G M Durie; J F S Miguel; J Blade; S V Rajkumar
Journal:  Leukemia       Date:  2015-10-21       Impact factor: 11.528

2.  Performance comparison of capillary and agarose gel electrophoresis for the identification and characterization of monoclonal immunoglobulins.

Authors:  Christopher R McCudden; Stephanie P Mathews; Shirley A Hainsworth; John F Chapman; Catherine A Hammett-Stabler; Monte S Willis; David G Grenache
Journal:  Am J Clin Pathol       Date:  2008-03       Impact factor: 2.493

3.  Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis.

Authors:  Kanji Miyazaki; Kenshi Suzuki
Journal:  Amyloid       Date:  2016-09-28       Impact factor: 7.141

4.  Evaluation of two automated capillary electrophoresis systems for human serum protein analysis.

Authors:  Céline Chartier; Anne Marie Boularan; Anne Marie Dupuy; Stéphanie Badiou; Anne Sophie Bargnoux; Chantal Cognot; Jean François Eliaou; Jean Paul Cristol
Journal:  Clin Biochem       Date:  2011-06-12       Impact factor: 3.281

5.  Comparison of capillary zone and immunosubtraction with agarose gel and immunofixation electrophoresis for detecting and identifying monoclonal gammopathies.

Authors:  C M Litwin; S K Anderson; G Philipps; T B Martins; T D Jaskowski; H R Hill
Journal:  Am J Clin Pathol       Date:  1999-09       Impact factor: 2.493

6.  Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice.

Authors:  Jonathan R Genzen; David L Murray; Gyorgy Abel; Qing H Meng; Richard J Baltaro; Daniel D Rhoads; Julio C Delgado; Rhona J Souers; Christine Bashleben; David F Keren; Mohammad Q Ansari
Journal:  Arch Pathol Lab Med       Date:  2017-12-21       Impact factor: 5.534

7.  Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.

Authors:  Natalia Tovar; Carlos Fernández de Larrea; Juan I Aróstegui; Maria Teresa Cibeira; Laura Rosiñol; Montserrat Rovira; Montserrat Elena; Xavier Filella; Jordi Yagüe; Joan Bladé
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

8.  An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins.

Authors:  Joannes F M Jacobs; Katherine A Turner; Maria Stella Graziani; Jody L Frinack; Michael W Ettore; Jillian R Tate; Ronald A Booth; Christopher R McCudden; David F Keren; Julio C Delgado; Galina Zemtsovskaja; Robert O Fullinfaw; Anna Caldini; Theo de Malmanche; Katina Katakouzinos; Matthew Burke; Giovanni Palladini; Sara Altinier; Martina Zaninotto; Gabriella Righetti; Marie Therese Melki; Stephen Bell; Maria Alice Vieira Willrich
Journal:  Clin Chem Lab Med       Date:  2020-03-26       Impact factor: 3.694

Review 9.  International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.

Authors:  Shaji Kumar; Bruno Paiva; Kenneth C Anderson; Brian Durie; Ola Landgren; Philippe Moreau; Nikhil Munshi; Sagar Lonial; Joan Bladé; Maria-Victoria Mateos; Meletios Dimopoulos; Efstathios Kastritis; Mario Boccadoro; Robert Orlowski; Hartmut Goldschmidt; Andrew Spencer; Jian Hou; Wee Joo Chng; Saad Z Usmani; Elena Zamagni; Kazuyuki Shimizu; Sundar Jagannath; Hans E Johnsen; Evangelos Terpos; Anthony Reiman; Robert A Kyle; Pieter Sonneveld; Paul G Richardson; Philip McCarthy; Heinz Ludwig; Wenming Chen; Michele Cavo; Jean-Luc Harousseau; Suzanne Lentzsch; Jens Hillengass; Antonio Palumbo; Alberto Orfao; S Vincent Rajkumar; Jesus San Miguel; Herve Avet-Loiseau
Journal:  Lancet Oncol       Date:  2016-08       Impact factor: 41.316

10.  Screening panels for detection of monoclonal gammopathies.

Authors:  Jerry A Katzmann; Robert A Kyle; Joanne Benson; Dirk R Larson; Melissa R Snyder; John A Lust; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Clin Chem       Date:  2009-06-11       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.